Actinium Pharmaceuticals Inc (ATNM)
6.56
-0.50
(-7.08%)
USD |
NYAM |
Apr 25, 16:00
6.78
+0.22
(+3.35%)
After-Hours: 07:21
Actinium Pharmaceuticals Cash from Operations (TTM): -47.34M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -47.34M |
| September 30, 2023 | -47.62M |
| June 30, 2023 | -42.21M |
| March 31, 2023 | -0.652M |
| December 31, 2022 | 8.644M |
| September 30, 2022 | 11.37M |
| June 30, 2022 | 11.50M |
| March 31, 2022 | -21.00M |
| December 31, 2021 | -20.87M |
| September 30, 2021 | -22.07M |
| June 30, 2021 | -21.48M |
| March 31, 2021 | -21.40M |
| December 31, 2020 | -21.62M |
| September 30, 2020 | -20.37M |
| June 30, 2020 | -20.97M |
| March 31, 2020 | -21.83M |
| December 31, 2019 | -21.46M |
| September 30, 2019 | -20.74M |
| June 30, 2019 | -21.75M |
| March 31, 2019 | -20.60M |
| December 31, 2018 | -20.57M |
| September 30, 2018 | -19.45M |
| June 30, 2018 | -18.71M |
| March 31, 2018 | -21.64M |
| December 31, 2017 | -21.55M |
| Date | Value |
|---|---|
| September 30, 2017 | -22.63M |
| June 30, 2017 | -22.33M |
| March 31, 2017 | -21.41M |
| December 31, 2016 | -20.79M |
| September 30, 2016 | -20.51M |
| June 30, 2016 | -18.44M |
| March 31, 2016 | -17.49M |
| December 31, 2015 | -18.54M |
| September 30, 2015 | -19.63M |
| June 30, 2015 | -20.37M |
| March 31, 2015 | -17.67M |
| December 31, 2014 | -14.35M |
| September 30, 2014 | -10.65M |
| June 30, 2014 | -8.027M |
| March 31, 2014 | -6.471M |
| December 31, 2013 | -6.292M |
| September 30, 2013 | -6.365M |
| June 30, 2013 | -6.678M |
| March 31, 2013 | -6.577M |
| December 31, 2012 | -5.213M |
| September 30, 2012 | -4.318M |
| June 30, 2012 | -2.385M |
| March 31, 2012 | -1.461M |
| December 31, 2011 | -0.5176M |
| September 30, 2011 | -0.0001M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-47.62M
Minimum
Sep 2023
11.50M
Maximum
Jun 2022
-19.05M
Average
-21.40M
Median
Mar 2021
Cash from Operations (TTM) Benchmarks
| Perspective Therapeutics Inc | -36.91M |
| Eli Lilly and Co | 4.240B |
| Cellectar Biosciences Inc | -32.38M |
| Bristol-Myers Squibb Co | 13.86B |
| Oragenics Inc | -7.291M |